Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06102902
Title Testing the Addition of Anti-cancer Drug, ZEN003694, to the Usual Chemotherapy Treatment, Cetuximab Plus Encorafenib, for Colorectal Cancer
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors National Cancer Institute (NCI)
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
USC / Norris Comprehensive Cancer Center RECRUITING Los Angeles California 90033 United States Details
Ohio State University Comprehensive Cancer Center RECRUITING Columbus Ohio 43210 United States Details
University of Oklahoma Health Sciences Center RECRUITING Oklahoma City Oklahoma 73104 United States Details
M D Anderson Cancer Center RECRUITING Houston Texas 77030 United States Details
University of Virginia Cancer Center RECRUITING Charlottesville Virginia 22908 United States Details
Virginia Commonwealth University/Massey Cancer Center RECRUITING Richmond Virginia 23298 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field